Format

Send to

Choose Destination
PLoS One. 2013 Nov 4;8(11):e78070. doi: 10.1371/journal.pone.0078070. eCollection 2013.

Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis.

Author information

1
Department of Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Erratum in

  • PLoS One. 2014;9(1). doi:10.1371/annotation/6633ed7f-a10c-4f6d-9d1d-9c1245822eb7. Huang, Jianwei [corrected to Wang, Jianwei].

Abstract

BACKGROUND:

The prognostic significance of circulating tumor cells (CTCs) detected in patients with non-small-cell lung cancer (NSCLC) is still inconsistent. We aimed to assess the prognostic relevance of CTCs using a meta-analysis.

METHODS:

We searched PubMed, Web of Science and EMBASE for relevant studies that assessed the prognostic relevance of CTCs in NSCLC. Statistical analyses were conducted to calculate the summary incidence, odds ratio, relative risks (RRs) and 95% confidence intervals (CIs) using fixed or random-effects models according to the heterogeneity of included studies.

RESULTS:

A total of 20 studies, comprising 1576 patients, met the inclusion criteria. In identified studies, CTCs were not correlated with histology (adenocarcinoma vs squamous cell carcinoma) (odds ratio [OR] = 0.88; 95% confidence interval [CI]: 0.59-1.33; Z = -0.61; P = 0.545). However, pooled analyses showed that CTCs were associated with lymph node metastasis (OR = 2.06; 95% CI: 1.18-3.62; Z = 2.20; P = 0.027) and tumor stage (OR = 1.95; 95% CI: 1.08-3.54; Z = 2.53; P = 0.011). Moreover, CTCs were significantly associated with shorter overall survival (relative risk [RR] = 2.19; 95% CI: 1.53-3.12; Z = 4.32; P<0.0001) and progression-free/disease-free survival (RR = 2.14; 95% CI: 1.36-3.38; Z = 3.28; P<0.0001).

CONCLUSION:

The presence of CTCs indicates a poor prognosis in patients with NSCLC. Further well-designed prospective studies are required to explore the clinical applications of CTCs in lung cancer.

PMID:
24223761
PMCID:
PMC3817175
DOI:
10.1371/journal.pone.0078070
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center